Genes Associated With Improved Survival for Pancreatic Cancer Patients Monday, August 24, 2015 Use of non-invasive liquid biopsies could predict in which patients the cancer could recur following surgery. Researchers Publish Landmark “Basket Study” Monday, August 24, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.Breakthrough Could Lead to New Antibiotics Friday, August 21, 2015 Scientists have exposed a chink in the armour of disease-causing bugs, with a new discovery about a protein that controls bacterial defences.Data Mining DNA For Polycystic Ovary Syndrome Genes Friday, August 21, 2015 A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.The Linking of Molecules and Microbes Thursday, August 20, 2015 Researchers have succeeded in making antibiotic substances and their bacterial producers simultaneously visible. So Long, Snout Thursday, August 20, 2015 Research helps answer how birds got their beaks. Researchers Develop qPCR Prognosis Test for NSCLC Patients Thursday, August 20, 2015 A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease. Genome Wide Annotation of Primary miRNAs Reveals Novel Mechanisms Thursday, August 20, 2015 Researchers have devised a strategy for genome-wide annotation of primary miRNA transcripts, providing extensive new annotations in human and mouse, and shedding light on mechanisms of regulation of microRNA gene expression.Genetic Test Could Improve Blood Cancer Treatment Thursday, August 20, 2015 Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.